110965 ⎘
ssRNA viruses negative-sense; Details; Paramyxoviridae; Morbillivirus, e.g. Measles virus, canine distemper; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
VIRAL VECTORS FOR NUCLEAR REPROGRAMMING
#2IMMUNOGENIC COMPOSITIONS FOR HERPES SIMPLEX VIRUS PROTEINS
#3RECOMBINANT MEASLES VIRUS
#4AMINO ACIDS, NUCLEOTIDES AND VECTORS EXPRESSING THE SAME AND USES THEREOF IN PREVENTING SARBECOVIRUS INFECTION
#5MEASLES-HIV OR MEASLES-HTLV VACCINE
#6CO-STIMULATORY 4-1BBL ECTODOMAIN POLYPEPTIDES FOR IMMUNOMODULATION
#7DNA MOLECULES PRODUCING CUSTOM DESIGNED REPLICATING AND NON-REPLICATING NEGATIVE STRANDED RNA VIRUSES AND USES THERE OF
#8DNA MOLECULES PRODUCING CUSTOM DESIGNED REPLICATING AND NON-REPLICATING NEGATIVE STRANDED RNA VIRUSES AND USES THERE OF
#9AN IMPROVED MEASLES VIRUS VACCINE VECTOR BASED ON MULTIPLE TANDEM ADDITIONAL TRANSCRIPTION UNITS (ATUS)
#10Measles virus vaccine expressing SARS-CoV-2 protein(s)
#11COMPOSITIONS AND METHODS COMPRISING MEASLES VIRUS DEFECTIVE INTERFERING PARTICLES FOR THE PREVENTION OF INFECTIOUS DISEASES
#12Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
#13Optically controlled virus protein, gene thereof, and virus vector containing said gene
#14Lassa vaccine
#15Paramyxoviridae expression system
#16DEGRON FUSION CONSTRUCTS AND METHODS FOR CONTROLLING PROTEIN PRODUCTION
#17Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
#18VIRAL VECTORS FOR NUCLEAR REPROGRAMMING
#19Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection
#20DNA molecules producing custom designed replicating and non-replicating negative stranded RNA viruses and uses there of
#21Optimized HIV envelope gene and expression thereof
#22Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases
#23RNA VIRUSES FOR IMMUNOVIROTHERAPY
#24Recombinant Zika vaccines
#25Chromatography based purification strategies for viruses
#26Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
#27Degron fusion constructs and methods for controlling protein production
#28Viral Targeting with Knottins
#29VIRUS VECTOR, CELL, AND CONSTRUCT
#30Optimized HIV envelope gene and expression thereof
#31RNA viruses expressing IL-12 for immunovirotherapy
#32Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection
#33Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
#34Methods to improve vector expression and genetic stability
#35Neutralization-resistant CDV mutants and viral vectors
#36Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
#37Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
#38Oncolytic measles virus
#39Recombinant measles virus expressing chikungunya virus polypeptides and their applications
#40Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection
#41Combined measles-malaria vaccine
#42Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
#43Methods to improve vector expression and genetic stability
#44Oncolytic measles virus
#45Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
#46Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
#47Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Malarial Infections
#48Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Nipah Infections
#49Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
#50Combined measles-malaria vaccine
#51CDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, and process for the production of such viruses encoding additional antigenically active proteins
#52VACCINE COMPOSITIONS
#53MEASLES VIRUS FOR THE ELIMINATION OF UNWANTED CELL POPULATIONS
#54Combined measles-human papilloma vaccine
#55Paramyxoviridae Virus Preparations
#56Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection
#57Paramyxoviridae virus preparations
#58cDNA corresponding to the antigenome of nonsegmented negative stranded RNA viruses and process for the production of such viruses
#59Infectious recombinant paramyxovirus from antigenomic cDNA
#60Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
#61Recombinant measles viruses expressing epitopes of antigens of RNA viruses - use for the preparation of vaccine compositions
#62Ablated SLAM-Dependent Entry
#63Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions